Matches in Wikidata for { <http://www.wikidata.org/entity/Q92102005> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q92102005 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q92102005 description "scientific article published on 01 July 2019" @default.
- Q92102005 description "wetenschappelijk artikel" @default.
- Q92102005 description "наукова стаття, опублікована 1 липня 2019" @default.
- Q92102005 name "Nonclinical Safety and Toxicokinetics of MnTE-2-PyP (BMX-010), a Topical Agent in Phase 2 Trials for Psoriasis and Atopic Dermatitis" @default.
- Q92102005 name "Nonclinical Safety and Toxicokinetics of MnTE-2-PyP (BMX-010), a Topical Agent in Phase 2 Trials for Psoriasis and Atopic Dermatitis" @default.
- Q92102005 type Item @default.
- Q92102005 label "Nonclinical Safety and Toxicokinetics of MnTE-2-PyP (BMX-010), a Topical Agent in Phase 2 Trials for Psoriasis and Atopic Dermatitis" @default.
- Q92102005 label "Nonclinical Safety and Toxicokinetics of MnTE-2-PyP (BMX-010), a Topical Agent in Phase 2 Trials for Psoriasis and Atopic Dermatitis" @default.
- Q92102005 prefLabel "Nonclinical Safety and Toxicokinetics of MnTE-2-PyP (BMX-010), a Topical Agent in Phase 2 Trials for Psoriasis and Atopic Dermatitis" @default.
- Q92102005 prefLabel "Nonclinical Safety and Toxicokinetics of MnTE-2-PyP (BMX-010), a Topical Agent in Phase 2 Trials for Psoriasis and Atopic Dermatitis" @default.
- Q92102005 P1433 Q92102005-9016D214-41E1-4EB0-BCB0-3FD77C712D62 @default.
- Q92102005 P1476 Q92102005-7DC1DEE4-15FA-4062-BD4D-735D1FE7142C @default.
- Q92102005 P2093 Q92102005-178BF5F5-FBD0-4263-BC6A-F6AE9F59A4C5 @default.
- Q92102005 P2093 Q92102005-26D92B07-AAD4-4882-9C20-30D2244D7472 @default.
- Q92102005 P2093 Q92102005-27A8A6DC-BE01-43B5-BC17-3DB941503CE4 @default.
- Q92102005 P2093 Q92102005-44E14840-51AE-4178-B71F-CA3298BD227C @default.
- Q92102005 P2093 Q92102005-FBF18635-0719-456C-9415-6B47BDD6A724 @default.
- Q92102005 P304 Q92102005-4A9C39D8-31A6-479E-BC69-60724CDAB4B0 @default.
- Q92102005 P31 Q92102005-BCACFF47-5962-4840-B5DE-37104F7A6415 @default.
- Q92102005 P356 Q92102005-498E7D98-4049-46FC-9F3B-D75B898B55CA @default.
- Q92102005 P433 Q92102005-F9469AAF-7C3A-4830-9408-A838EB5D32DF @default.
- Q92102005 P478 Q92102005-9237EBB7-8C51-4EA6-A25E-B829174BA468 @default.
- Q92102005 P577 Q92102005-A95C0196-98FA-477B-A6C0-B9C8BA51B206 @default.
- Q92102005 P698 Q92102005-BB7A1217-6011-4A92-814F-EF6A02F72CF2 @default.
- Q92102005 P921 Q92102005-31AF1D72-3A8A-4699-9CD7-BD2B3FB81A5E @default.
- Q92102005 P921 Q92102005-EEDB2EFF-6EC7-4887-8FE2-68CA57D5D2D6 @default.
- Q92102005 P356 1091581819852325 @default.
- Q92102005 P698 31333066 @default.
- Q92102005 P1433 Q1307411 @default.
- Q92102005 P1476 "Nonclinical Safety and Toxicokinetics of MnTE-2-PyP (BMX-010), a Topical Agent in Phase 2 Trials for Psoriasis and Atopic Dermatitis" @default.
- Q92102005 P2093 "Cesar V Mujer" @default.
- Q92102005 P2093 "Charles B Spainhour" @default.
- Q92102005 P2093 "Dexter W Sullivan" @default.
- Q92102005 P2093 "James D Crapo" @default.
- Q92102005 P2093 "Shayne C Gad" @default.
- Q92102005 P304 "291-302" @default.
- Q92102005 P31 Q13442814 @default.
- Q92102005 P356 "10.1177/1091581819852325" @default.
- Q92102005 P433 "4" @default.
- Q92102005 P478 "38" @default.
- Q92102005 P577 "2019-07-01T00:00:00Z" @default.
- Q92102005 P698 "31333066" @default.
- Q92102005 P921 Q268667 @default.
- Q92102005 P921 Q42824440 @default.